No Result
View All Result
  • Private Data
  • Membership options
  • Login
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Home COUNTRY DACH

Just what the doctor ordered: Saventic Health raises €1.9 million to diagnose rare diseases with AI

EU Startupsby EU Startups
December 10, 2024
Reading Time: 3 mins read
in DACH, VENTURE CAPITAL
Share on FacebookShare on Twitter

Saventic Health, a Warsaw-based startup advancing the diagnosis of rare diseases using AI, has secured €1.9 million in bridge funding from international investors.

This investment was led by 4growth VC in co-investment with Poland’s NCBR Investment Fund and the U.S.-based TNI Fund. The funds will support the company’s continued expansion into new markets, including Europe, South America, and Canada, while setting the stage for a larger Series A funding round in the near future.

“Our international presence confirms that our algorithms are effective and well-received by our clients and partners,” said Szymon Piątkowski, Co-founder and CEO of Saventic Health. “The healthcare, biotechnology, and innovation sectors are currently building a completely new market from scratch, fueled by the AI revolution. Our startup culture and highly skilled team enable us to be one of the key players in this field.”

Founded in 2019 by Szymon Piątkowski and Professor Grzegorz Basak, Saventic Health develops AI algorithms designed to assist in diagnosing rare diseases more effectively and efficiently than traditional methods. With 50 algorithms currently in use, the company has already diagnosed over 200 individuals with rare conditions in the past year.

Its solutions are deployed globally, with projects running in partnership with 11 of the 30 largest pharmaceutical companies and over 30 clinics and hospitals across Poland, Germany, France, Brazil, and Canada.

The 40-member team at Saventic Health is made up of doctors, data scientists, and data engineers focused on leveraging AI for healthcare innovation.

The company’s AI-driven technology analyses medical records to identify potential rare disease diagnoses that affect 450 million people worldwide, providing suggestions for further action to physicians. According to Saventic Health, this approach achieves far greater efficiency compared to traditional diagnostic methods, which often require 7-12 years for an accurate diagnosis and succeed only 2-4% of the time.

“We are now focusing on entering the Austrian, Swedish, Spanish, and Italian markets, leveraging the fact that our algorithms are registered as medical devices across the European Union. We are also expanding our presence in South America, where our solutions are similarly certified as medical products. In addition to Brazil, where we already have ongoing projects, we are beginning operations in Colombia, Peru, and other digitally advanced countries in the region,” Piątkowski added.

The company’s growth strategy includes targeting new markets and increasing geographic diversification, with plans to expand operations into countries such as Colombia and Peru. Saventic Health also plans to enter the U.S. market following the completion of its upcoming Series A funding round.

The new funding marks the first investment from TNI Fund, part of the Kluz Ventures group, which focuses on transformative technologies in healthcare. “Our fund focuses on breakthrough technologies in healthcare and their practical applications to solve global problems. Saventic Health provides innovative patient diagnostic solutions, which we believe represent the future of healthcare,” said Artur Kluz, General Partner at TNI Fund.

4growth VC, which initially invested €2 million in Saventic Health in 2022, also increased its stake in this round. “The inclusion of a U.S. fund among its investors confirms Saventic Health’s global potential,” said Tomasz Biłous, Managing Partner at 4growth VC. “The company is already active on three continents and has global agreements with the largest pharmaceutical players. Thanks to fully digitalized processes, Saventic Health can execute projects for its clients and assist in diagnosing patients wherever needed, enabling dynamic international growth.”

“We are pleased to witness the company’s dynamic development, which reassures us about the quality of this investment. Saventic Health’s current expansion and the ambitious plans of its founders have convinced us to increase our capital commitment. This highlights the importance of public-private capital collaboration, which jointly provides innovative Polish companies with greater opportunities to build global potential,” said Ksenia Wójcik Karasiewicz, CEO of NCBR Investment Fund.

Read the orginal article: https://www.eu-startups.com/2024/12/just-what-the-doctor-ordered-saventic-health-raises-e1-9-million-to-diagnose-rare-diseases-with-ai/

Gateways to Italy

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

by Partner
June 6, 2023

Sign up to our newsletter

SIGN UP

Related Posts

GREEN

Startups rally against AI Act ahead of crunch EU meeting

July 1, 2025
UK&IRELAND

British startup Mozart AI raises €616k for its AI-powered Digital Audio Workstation

July 1, 2025
FINTECH

Zango AI Emerges From Stealth, Raising $4.8m to Revolutionise Financial Compliance Systems with AI Agents

July 1, 2025

ItaHub

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Italy’s SMEs export toward 260 bn euros in 2025

Italy’s SMEs export toward 260 bn euros in 2025

September 9, 2024
With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

April 23, 2024
EU’s AI Act, like previous rules on technology,  looks more defensive than investment-oriented

EU’s AI Act, like previous rules on technology, looks more defensive than investment-oriented

January 9, 2024

Co-sponsor

Premium

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

March 6, 2025
Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

February 10, 2025
Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Venture capital investments top €1.3bn in 208 rounds as of Sep30  in Italy. They were €1.5 in all 2023. The new BeBeez Report

Venture capital investments top €1.3bn in 208 rounds as of Sep30 in Italy. They were €1.5 in all 2023. The new BeBeez Report

October 28, 2024
Next Post

Gooddrop’s ‘grow-to-wear’ apparel business looks to mass produce cotton using vertical farms

White & Case advises Partners Group and Investec on financing of Duke Street’s acquisition of ForLife Group

EdiBeez srl

C.so Italia 22 - 20122 - Milano
C.F. | P.IVA 09375120962
Aut. Trib. Milano n. 102
del 3 aprile 2013

COUNTRY

Italy
Iberia
France
UK&Ireland
Benelux
DACH
Scandinavia&Baltics

CATEGORY

Private Equity
Venture Capital
Private Debt
Distressed Assets
Real Estate
Fintech
Green

PREMIUM

ItaHUB
Legal
Tax
Trend
Report
Insight view

WHO WE ARE

About Us
Media Partnerships
Contact

INFORMATION

Privacy Policy
Terms&Conditions
Cookie Police

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHub
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • Login
  • Cart